Skip to main content

Pharma firm plans to import Covid-19 treatment drug from Bangladesh

KARACHI: A local pharmaceutical company plans to import a generic version of remdesivir — a broad spectrum antiviral medication that has shown to reduce recovery time in Covid-19 patients — from a Bangladesh-based manufacturer.

The drug has been granted emergency use authorisation by the US Food and Drug Administration (FDA) and authorities in Japan and the UK to treat hospitalised patients with severe manifestations of coronavirus.

According to a statement released by Searle Company Limited on Friday, the firm has entered into an exclusive licensing and marketing agreement with Beximco Pharmaceuticals, Bangladesh.

“It’s the first company in the world to introduce the generic variant of the drug. Our partnership will provide an immediate supply of the finished product at an affordable price and will help healthcare providers of Pakistan to treat their hospitalised Covid-19 patients without any delay,” said Mohammad Sajid, business development director at Searle.

Company asks authorities for urgent regulatory approval

The company decided not to make any commercial profit from the import (till the time the pandemic is over) and also to donate it to the government and Covid-19-designated hospitals, he added.

Asked about drug price in Bangladesh and its dosage, Mr Sajid said it cost around $70 per vial and six to a dozen vials were administered to a patient depending upon disease’s severity.

“Remdesivir is a direct-acting viral drug that inhibits viral RNA (Ribonucleic acid) synthesis. It is administrated intravenously and is authorized for the treatment of hospitalized patients with severe Covid-19 infection.”

Searle, he said, was actively taking the matter to the relevant authorities of Pakistan for necessary regulatory approval and was confident that in the existing pandemic, the relevant authorities would consider the matter on an urgent basis to support the product availability.

“Meanwhile, the drug would be imported under the patient access programme, which allows import when hospitals make a demand.”

Bangladesh, according to experts, has made remarkable progress in the pharmaceutical sector in recent years.

Some Bangladesh-based pharmaceutical companies, they said, were approved by the FDA and exported their products to the US. The global trade rules allow nations defined by the United Nations as least-developed countries (LDCs) to manufacturer patented drugs to make them more affordable in their markets. Bangladesh is one of 47 countries that fall in this category while Pakistan is not.

Remdesivir is currently undergoing clinical trials around the world, including in the UK. Early data suggests it can cut recovery time by about four days, but so far there has been no evidence that it will save more lives.

Earlier this month, Ferozsons Laboratories Limited, a subsidiary of BF Biosciences Ltd, said it would make the drug in Pakistan after signing a non-exclusive licensing pact with the US-based Gilead, which manufactured the drug, to make and sell the drug to 127 nations. However, the pharmaceutical company had announced that its production could take weeks.

Published in Dawn, May 30th, 2020



from The Dawn News - Home https://ift.tt/2AiH1wC
via IFTTT

Comments

Popular posts from this blog

Trump says he urged team to ‘slow’ COVID-19 testing

US President Donald Trump said Saturday he was encouraging health officials in his administration to slow down coronavirus testing, arguing that increased tests lead to more cases being discovered. The president has claimed falsely on several occasions that surges of COVID-19 in several states can be explained by greater numbers of diagnostic tests. At his first rally since the outbreak forced nationwide shutdowns in March, Trump told the crowd in Tulsa, Oklahoma that testing was a “double-edged sword.” The United States — which has more deaths and cases than any other country — has carried out more than 25 million coronavirus tests, placing it outside the top 20 countries in the world, per capita. “Here is the bad part: When you do testing to that extent, you are going to find more people, you will find more cases,” Trump argued. “So I said to my people ‘slow the testing down.’ They test and they test.” It was not clear from Trump’s tone if he was playing to the crowd, who ...

Sir Anwer Pervez, richest Pakistani British businessman, loses £432m in pandemic

Sir Anwar Pervez OBE, the founder and chairman of Bestway Cash & Carry has lost £432 million during the coronavirus pandemic to bring him down to No 50 on the richest British people list. The list has 1,000 people and is published by the Sunday Times newspaper . Pervez was at No 42 previously.  The 2020 list of the UK’s richest shows its first fall in wealth in a decade as Britain’s wealthiest people lost tens of billions of pounds in the coronavirus pandemic, the Sunday Times reported in its Rich List 2020. The newspaper, which has produced the respected annual ranking of the country’s 1,000 wealthiest people since 1989, found the past two months had resulted in the super-rich losing £54 billion ($65 billion). More than half of the billionaires in Britain had seen drops in their worth by as much as £6b, a decrease in their collective wealth unprecedented since 2009 and the financial crisis. The Hinduja brothers, who topped last year’s list with a £22b fortune, saw among ...

Despite reservations about jury, Pakistan to implement FATF reforms: envoy

WASHINGTON: Despite its reservations about the fairness of the jury which is to determine Pakistan’s performance against terror financing, the government is committed to implementing its action plan for dealing with this issue, says Islamabad’s Washington envoy Asad Majeed Khan. In a conversation with a prominent US scholar George Perkovich, recorded at the Carnegie Endowment for International Peace in Washington on Monday afternoon, Ambassador Khan said the actions that Pakistan had taken so far to eliminate terror financing were “reflective of the political will”. “We feel that we have done a lot. We are also clear and determined to do more,” said the envoy while responding to a question about a meeting of the Financial Action Task Force (FATF) held in Orlando last week, which asked Pakistan to implement its own action plan for eliminating terror financing by October. Failing to do so could put Pakistan on a blacklist of violators and bring strict economic sanctions too. “But we w...